In the case of breast cancer, higher expression levels of PRKDC were significantly associated with shorter overall survival, higher tumor grade, and positive lymph node status in patients, while downregulation sensitized MCF-7 cell lines to chemotherapeutics in vitro and in xenograft models [22]. This evidence concerns the gene PRKDC and breast carcinoma.